<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T10:23:20Z</responseDate><request verb="GetRecord" identifier="oai:repository.ajou.ac.kr:201003/13021" metadataPrefix="oai_dc">https://repository.ajou.ac.kr/oai/request</request><GetRecord><record><header><identifier>oai:repository.ajou.ac.kr:201003/13021</identifier><datestamp>2024-10-11T02:21:24Z</datestamp><setSpec>com_201003_14372</setSpec><setSpec>com_201003_14368</setSpec><setSpec>col_201003_14374</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Protective effect of TM-25659, known as TAZ activator, on high-fat diet-induced insulin resistance in C57BL/6J mice</dc:title>
<dc:title>TAZ 활성제로 알려진, TM-25659가 고지방 식이로 유도된 인슐린 저항성 마우스에 미치는 효과</dc:title>
<dc:creator>정, 종갑</dc:creator>
<dc:contributor>이, 관우</dc:contributor>
<dc:contributor>대학원 의생명과학과</dc:contributor>
<dc:contributor>200724304</dc:contributor>
<dc:contributor>정, 종갑</dc:contributor>
<dc:subject>TAZ</dc:subject>
<dc:subject>TM-25659</dc:subject>
<dc:subject>insulin resistance</dc:subject>
<dc:subject>FGF21</dc:subject>
<dc:subject>AMPK</dc:subject>
<dc:description>PART 1. TM-25659-induced activation of FGF21 level decreases insulin resistance and inflammation in skeletal muscle via GCN2 pathways    1 &#xd;
&#xd;
Ⅰ. INTRODUCTION 2 &#xd;
&#xd;
Ⅱ. MATERIALS AND METHODS 8 &#xd;
&#xd;
  A. MATERIALS 9 &#xd;
&#xd;
  B. METHODS 10 &#xd;
&#xd;
  1. Preparation of PA 10 &#xd;
&#xd;
  2. Cell culture 10 &#xd;
&#xd;
  3. Immunoblot analysis 11 &#xd;
&#xd;
  4. RNA isolation and quantitative real-time polymerase chain reaction (PCR) 12 &#xd;
&#xd;
  5. siRNAs 13 &#xd;
&#xd;
  6. Uptake of 2-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino-2-deoxyglucose (2-NBDG) 14 &#xd;
&#xd;
  7. Animal experiments 14 &#xd;
&#xd;
  8. FGF21 secretion 15 &#xd;
&#xd;
  9. IL-1&amp;beta; assay 15 &#xd;
&#xd;
  10. Statistical analysis 15 &#xd;
&#xd;
Ⅲ. RESULTS 16 &#xd;
&#xd;
  A. TM-25659 restored PA-induced insulin resistance and inflammation in skeletal muscle cells 17 &#xd;
&#xd;
  B. TM-25659 increased FGF21 levels by GCN2 pathways in skeletal muscle cells 22 &#xd;
&#xd;
  C. Effects of TM-25659 reduced insulin resistance and inflammation in skeletal muscle cells treated with or without FGF21 siRNA 27 &#xd;
&#xd;
  D. TM-25659 prevented HF-diet induced obesity 31 &#xd;
&#xd;
  E. TM-25659 restored the insulin signaling pathways in DIO mice skeletal muscle   33 &#xd;
&#xd;
  F. TM-25659 lowered the muscle pro-inflammatory cytokine levels in DIO mice   35 &#xd;
&#xd;
  G. TM-25659 regulates expression of both FGF21 mRNA and protein in DIO mice skeletal muscles 37 &#xd;
&#xd;
Ⅳ. DISCUSSION 38 &#xd;
&#xd;
Ⅴ. CONCLUSION 42 &#xd;
&#xd;
PART 2. Protective effects of TM-25659 on high-fat diet-induced insulin resistance in liver via AMPK pathways    44 &#xd;
&#xd;
Ⅰ. INTRODUCTION 45 &#xd;
&#xd;
Ⅱ. MATERIALS AND METHODS 52 &#xd;
&#xd;
  A. MATERIALS 53 &#xd;
&#xd;
  B. METHODS 54 &#xd;
&#xd;
  1. Preparation of PA 54 &#xd;
&#xd;
  2. Cell culture 54 &#xd;
&#xd;
  3. Immunoblot analysis 54 &#xd;
&#xd;
  4. RNA isolation and quantitative real-time polymerase chain reaction (PCR) 55 &#xd;
&#xd;
  5. Animal experiments 56 &#xd;
&#xd;
  6. Insulin tolerance tests 57 &#xd;
&#xd;
  7. Glucose tolerance tests 57 &#xd;
&#xd;
  8. Statistical analysis 57 &#xd;
&#xd;
Ⅲ. RESULTS 58 &#xd;
&#xd;
  A. TM-25659 restored PA-induced reduction of insulin signaling pathway and induction of in flammation in HepG2 cells 59 &#xd;
&#xd;
  B. TM-25659 increased AMPK and ACC phosphorylation in HepG2 cells 62 &#xd;
&#xd;
  C. TM-25659 reduced PA-induced reduction of insulin signaling pathway in HepG2 cells 65 &#xd;
&#xd;
  D. TM-25659 reduced PA-induced reduction of inflammation in HepG2 cells 67 &#xd;
&#xd;
  E. TM-25659 improved glucose homeostasis and insulin sensitivity in DIO mice 69 &#xd;
&#xd;
  F. TM-25659 restored the insulin signaling pathways in DIO mice liver 71 &#xd;
&#xd;
  G. TM-25659 lowered the serum and liver pro-inflammatory cytokine levels in DIO mice 73 &#xd;
&#xd;
  H. TM-25659 activated AMPK pathways in DIO mice liver 77 &#xd;
&#xd;
  I. TM-25659 repressed serum lipid levels in HF-diet fed mice 79 &#xd;
&#xd;
  J. TM-25659 prevented HF-diet induced hepatic steatosis 81 &#xd;
&#xd;
  K. TM-25659 reduced expression of lipogenic genes but increased expression of fatty acid oxidation genes in HF diet-fed mice 83 &#xd;
&#xd;
Ⅳ. DISCUSSION 85 &#xd;
&#xd;
Ⅴ. CONCLUSION 88 &#xd;
&#xd;
REFERENCES 90 &#xd;
&#xd;
국문요약 108</dc:description>
<dc:description>Doctor</dc:description>
<dc:date>2016-11-27T23:06:05Z</dc:date>
<dc:date>2016-11-27T23:06:05Z</dc:date>
<dc:date>2016</dc:date>
<dc:date>2016</dc:date>
<dc:type>Thesis</dc:type>
<dc:type>Theses</dc:type>
<dc:identifier>http://repository.ajou.ac.kr/handle/201003/13021</dc:identifier>
<dc:identifier>http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000021474</dc:identifier>
<dc:identifier>000000021474</dc:identifier>
<dc:language>en</dc:language>
<dc:format>application/pdf</dc:format>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>